Tissue expander with integrated drainage and infusion assembly

By introducing a single injection port, needle guard and movable barrier membrane into the tissue expander, combined with a one-way check valve and magnet system, the problem of fluid drainage difficulties after surgery is solved, and the convenience of inflation and drainage is achieved and the lightness of the equipment.

CN113271885BActive Publication Date: 2024-11-22MENTOR WORLDWIDE LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201980087398.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-10-24
Filing Date
2019-10-28
Publication Date
2024-11-22
Estimated Expiration
2039-10-28

AI Technical Summary

Technical Problem

Existing tissue dilators cannot effectively drain the fluid gathered around the device after surgery, resulting in patients requiring frequent clearance of surgical drainage tubes, and tissue dilators lacking a single injection port cannot be swelled and drained simultaneously.

Method used

Designed a tissue dilator with a single injection port, including a needle guard and a movable barrier membrane, to achieve inflation and drainage functions through a one-way check valve and magnet system, allowing for daily attachment of drainage tubes after surgery The serophthalmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmosmos

Benefits of technology

This design makes tissue dilators easier to fold, weight less, MRI visualization improves, and reduces metal usage, enabling the convenience of not having to frequently clear the drain tube after surgery.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113271885B_ABST
    Figure CN113271885B_ABST
Patent Text Reader

Abstract

The present invention discloses a tissue expander with an integrated drainage tube, the tissue expander comprising a shell having an opening and one or more drainage holes. An injection port is disposed in the opening of the shell and forms a fluid-tight seal with the shell. The injection port comprises a needle guard having a needle guard base with a top surface and a barrier membrane covering the top surface of the needle guard base. The barrier membrane defines an inflation chamber and a drainage chamber, the inflation chamber being located between the top surface of the needle guard base and the bottom surface of the barrier membrane, the drainage chamber covering the top surface of the barrier membrane. The tissue expander comprises one or more inflation ports, the one or more inflation ports being in fluid communication with the inflation chamber for inflating and deflating the shell with a first fluid. A drainage conduit is in fluid communication with the drainage chamber and the one or more drainage holes and extends between them to drain a second fluid from outside the shell.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This patent application claims the benefit of U.S. Provisional Patent Application No. 62 / 752,813, filed on October 30, 2018, and is related to U.S. Provisional Patent Application No. 62 / 752,839, filed on October 30, 2018, the disclosures of which are hereby incorporated by reference herein. Background Art Technical Field

[0003] The present patent application relates generally to implantable devices and, more particularly, to tissue expanders having integrated drainage and fluid delivery components.

[0004] Description of Related Technology

[0005] Tissue expanders are devices that are implanted beneath the skin or muscle and then gradually inflated to stretch overlying tissue. Expanders are often used to create a pocket for receiving a permanent prosthesis, or to create increased skin surface area where new skin for grafting or reconstruction is contemplated.

[0006] Tissue expanders are typically formed from a silicone polymer shell. After implantation, a fluid (such as saline) is periodically injected into the tissue expander to cause it to expand over time. During the injection, the surrounding skin is allowed to stretch and grow to create an increased skin surface and an increased tissue pocket to accommodate a permanent implant. Typically, a tissue expander has an injection element through which fluid can be introduced into or withdrawn from the expander. One such injection element is an integrated port with a septum that can be pierced by a hypodermic needle for introducing fluid into or withdrawing fluid from the expander. Alternatively, the injection element can be a self-sealing area on the tissue expander that allows penetration by a hypodermic needle and self-closes after the needle has been withdrawn from the expander.

[0007] Conventional, commercially available tissue expanders have a single port for inflating and deflating the shell of the tissue expander. They do not have a means for draining fluid (eg, a seroma) that forms around the outside of the shell of the tissue expander after the tissue expander is implanted.

[0008] After surgery, patients are often placed with surgical drains to prevent blood and lymph from accumulating under the skin, allowing for faster recovery. Some patients are sent home with drains implanted in the body and connected to external reservoirs. Emptying these reservoirs can be traumatic because the patient must measure and empty the reservoir periodically (e.g., every morning). Many patients hate surgical drains and look forward to having them removed.

[0009] In view of the above problems, there is a need for a tissue expander with a single injection port that can be used to inflate and deflate the tissue expander and drain fluid that collects around the tissue expander after surgery. There is also a need for a tissue expander with a single injection port that can be used to inflate / deflate, drain fluid, and infuse fluid (e.g., antibiotic solution) around the exterior of the implanted tissue expander. In addition, there remains a need for a tissue expander that removes seroma fluid without requiring a drain tube that is attached to the patient 24 hours a day. Summary of the invention

[0010] In one embodiment, the tissue expander preferably has a single injection port that can be used to inflate and deflate the tissue expander and drain fluid that forms around the exterior of the tissue expander after the tissue expander is implanted. Having a single injection port allows the empty tissue expander to be more easily folded and have a smaller profile, which reduces the size of the incision required for implantation. In addition, having a single injection port advantageously reduces the overall metal content of the tissue expander, which helps with MRI visualization and patient radiation. In addition, having only one injection port (less metal content than a tissue expander with two injection ports) will reduce the overall weight of the tissue expander.

[0011] In one embodiment, the injection port advantageously includes a needle guard having a needle guard base and a needle guard edge protruding upward from the needle guard base. In one embodiment, the needle guard may be made of metal. In one embodiment, the needle guard may be made of a polymer material such as plastic. The injection port preferably includes a barrier membrane positioned in the needle guard. The barrier membrane divides the injection port into two different chambers, namely an inflation chamber and a drainage chamber, wherein the inflation chamber is in fluid communication with one or more inflation / deflation ports for inflating and deflation of the tissue expander, and the drainage chamber is in fluid communication with one or more drainage ports for draining fluid collected outside the tissue expander.

[0012] In one embodiment, the shape, size and configuration of the barrier membrane of the injection port form a space without blocking the inflation / deflation port of the tissue barrier. The drainage chamber is coupled to the drainage port and at least one drainage conduit (e.g., a tube) connected to at least one drainage hole formed in the housing of the tissue expander. In one embodiment, the drainage conduit advantageously includes a one-way check valve (e.g., a duckbill valve). In one embodiment, the one-way check valve allows fluid (e.g., a seroma) to be withdrawn from the tissue surrounding the tissue expander without the possibility of inadvertently delivering saline into the patient.

[0013] In one embodiment, a first conventional injection needle can be used to inflate and deflate the tissue expander with a fluid (e.g., a saline solution). In one embodiment, the first needle is a standard injection needle used for inflation and deflation of the tissue expander. In one embodiment, the first needle can be used to inject a solution (e.g., a saline solution) into the housing to increase the size of the tissue expander. The first needle can also be used to remove a solution from the housing to reduce the size of the tissue expander.

[0014] In one embodiment, a second specially designed needle, referred to as a drainage needle, can be used to drain fluid (e.g., seroma) that accumulates around the housing of the tissue expander after the tissue expander is implanted. In one embodiment, the second drainage needle is used only for drainage. The drainage needle advantageously includes a hollow cylindrical shaft made of medical grade material (e.g., stainless steel). In one embodiment, the distal end of the hollow cylindrical shaft is closed and has a sharp tip. The drainage needle preferably includes a side port formed in the side of the hollow needle shaft, which is spaced proximally from the sharp tip. The side port advantageously enables fluids such as seroma fluids to be drawn into the drainage needle. The distance between the side port opening and the sharp distal tip preferably positions the side port to communicate with the drainage chamber, as described in more detail herein.

[0015] In one embodiment, the tissue expander preferably includes an integrated drainage and infusion system. In one embodiment, the tissue expander advantageously has a single injection port that can be used to inflate and deflate the tissue expander, to drain fluid that accumulates around the tissue expander after surgery and tissue expander implantation, and to deliver fluid around the exterior of the housing after implantation.

[0016] In one embodiment, a tissue expander with an integrated drainage tube preferably includes a shell having an opening and one or more drainage holes, and an injection port disposed in the opening of the shell and forming a fluid-tight seal with the shell, the injection port including a needle barrier having a needle barrier base with a top surface. In one embodiment, the injection port preferably includes a movable barrier covering the top surface of the needle barrier base. In one embodiment, the movable barrier is movable between a first position for inflating and deflating the shell with a first fluid and a second position for draining a second fluid from outside the shell.

[0017] In one embodiment, a magnet is coupled to the movable barrier membrane. In one embodiment, a compressible spring is connected to the magnet. In one embodiment, when the movable barrier membrane moves from the first position to the second position, the compressible spring is compressed to store energy. The energy can be released to return the membrane to the first position.

[0018] In one embodiment, the needle may cover the injection port and the second magnet may be coupled to the needle. In one embodiment, the second magnet repels the first magnet coupled to the movable barrier to move the movable barrier from the first position to the second position.

[0019] In one embodiment, the tissue expander preferably includes an inflation port for inflating the housing with a first fluid, and a drainage port for draining a second fluid from outside the housing. In one embodiment, when the movable barrier membrane is in the first position, the inflation port is open and the drainage port is closed. In one embodiment, when the movable barrier membrane is in the second position, the inflation port is closed and the drainage port is open.

[0020] In one embodiment, the tissue expander preferably includes an injection port having a movable barrier membrane that divides the injection port into an inflation chamber for inflating and deflating the tissue expander, and a drainage chamber for removing fluid that tends to collect around the implant after surgery. In one embodiment, the movable barrier membrane is connected to a magnet that is in turn coupled to a compressible spring. The barrier membrane is movable between a first extended position in which the connected spring is extended and a second retracted position in which the spring is compressed so that energy is stored in the spring.

[0021] In one embodiment, a first syringe with a needle is used to inflate and deflate the tissue expander. In one embodiment, a second syringe with a second needle contains an opposite polarity magnet to repel a magnet coupled to a movable membrane to block various openings. In the extended position, the movable barrier membrane blocks the drainage port, wherein a compression spring holds the movable barrier membrane in place (i.e., in the extended position). With the barrier membrane in the extended position, saline injection for inflation and deflation is achieved. The magnet mounted on the second syringe will repel the magnet coupled to the barrier membrane to push the movable barrier membrane downward, thereby allowing drainage via syringe aspiration.

[0022] In one embodiment, a tissue expander with an integrated drainage tube preferably includes a shell having an opening and one or more drainage holes, and an injection port disposed in the opening of the shell and forming a fluid-tight seal with the shell. In one embodiment, the injection port may include a needle barrier having a needle barrier base with a top surface and a barrier membrane covering the top surface of the needle barrier base. In one embodiment, the barrier membrane defines an inflation chamber located between the top surface of the needle guard base and the bottom surface of the barrier membrane, and a drainage chamber covering the top surface of the barrier membrane. In one embodiment, one or more inflation ports are fluidly connected to the inflation chamber for inflating and deflating the shell with a first fluid. In one embodiment, a drainage conduit is fluidly connected to the drainage chamber and one or more drainage holes and extends between them to drain a second fluid from outside the shell.

[0023] In one embodiment, the first needle is used to inflate the shell, and the second needle is used to drain fluid from the outer periphery of the shell. In one embodiment, the first needle has an opening at the sharp distal end. In one embodiment, the first needle is suitable for insertion into the injection port so that the opening at the sharp distal end is aligned with the inflation chamber to selectively inflate and deflate the shell with a first fluid. In one embodiment, the second needle has a closed distal end and a side port spaced proximally from the closed distal end. The second needle is suitable for insertion into the injection port so that the side port of the second needle is aligned with the drainage chamber to drain the second fluid from the outside of the shell.

[0024] In one embodiment, the tissue expander may include an infusion chamber covering the top surface of the barrier membrane and separated from the drainage chamber, and an infusion conduit fluidly connected to the infusion chamber and at least one of the drainage holes and extending therebetween for delivering the infusion fluid to the outside of the shell.

[0025] In one embodiment, the tissue expander includes a needle assembly adapted to be inserted into the injection port assembly. In one embodiment, the needle assembly has a first configuration and a second configuration, wherein the inflation lumen of the needle assembly is in fluid communication with the inflation chamber to selectively inflate and deflate the housing using a first fluid, and wherein the drainage lumen of the needle assembly is in fluid communication with the drainage chamber to drain a second fluid from outside the housing.

[0026] In one embodiment, the needle assembly preferably includes a needle having an elongated shaft having a proximal end and a distal end. In one embodiment, the needle advantageously includes an inflation lumen and a drainage lumen, the inflation lumen being located at the distal end of the elongated shaft aligned with the inflation chamber, and the drainage lumen being located proximal to the inflation lumen aligned with the drainage chamber, whereby the barrier membrane separates the inflation lumen from the drainage lumen.

[0027] In one embodiment, the needle assembly includes an insert disposed within the elongated shaft of the needle, the insert being movable between an extended position in which the inflation lumen is open and the drainage lumen is closed, and a retracted position in which the inflation lumen is closed and the drainage lumen is open.

[0028] In one embodiment, the insert of the needle assembly preferably includes an elongated shaft having an open proximal end, a distal end closed by a distal end wall, and an elongated conduit extending from the proximal end to the distal end of the insert. In one embodiment, the insert preferably has a side port formed in the outer wall of the elongated shaft of the insert that communicates with the elongated conduit of the insert. In one embodiment, the side port of the insert is aligned with the inflation lumen of the needle when the insert is in the extended position, and the side port of the insert is aligned with the drainage lumen of the needle when the insert is in the retracted position.

[0029] In one embodiment, the needle guard advantageously has a needle guard edge extending upwardly from the needle guard base.

[0030] In one embodiment, the barrier membrane support protrudes from the top surface of the needle guard base and toward the bottom surface of the barrier membrane for supporting the underside of the barrier membrane.

[0031] In one embodiment, the injection port assembly preferably includes an injection dome secured to the upper end of the needle guard rim. In one embodiment, the injection dome advantageously includes a base having a bottom surface with an annular groove formed therein, whereby the upper end of the needle guard rim is disposed within the annular groove of the injection dome for securing the injection dome to the needle guard.

[0032] In one embodiment, the needle guard rim has a first height and the injection dome has a second height that is less than the first height of the needle guard rim.

[0033] In one embodiment, the needle guard edge has one or more assembly openings formed therein, which are positioned adjacent to the upper end of the needle guard edge. In one embodiment, the one or more assembly openings are disposed in an annular groove of the injection dome.

[0034] In one embodiment, the drainage port passes through the edge of the needle guard for interconnecting the drainage chamber and the drainage conduit. In one embodiment, the drainage port is located between the bottom surface of the base of the injection dome and the needle guard base.

[0035] In one embodiment, a silicone material (e.g., uncured silicone) such as a silicone sheet preferably covers the upper end of the needle guard edge and contacts one or more component openings formed in the needle guard edge for securing the injection dome to the upper end of the needle guard edge.

[0036] In one embodiment, the drainage chamber is located between the bottom surface of the injection dome and the top surface of the barrier membrane.

[0037] In one embodiment, the one or more inflation ports pass through a lateral opening provided in the edge of the needle guard. In one embodiment, the one or more inflation ports are located between the drainage port and the top surface of the needle guard base.

[0038] In one embodiment, the drainage conduit preferably has a second end coupled to the drainage tube, which in turn is in fluid communication with one or more drainage holes formed in the housing.

[0039] In one embodiment, the tissue expander may include a drainage manifold that aligns with and covers one or more drainage holes formed in the housing.

[0040] In one embodiment, the drainage manifold includes a drainage manifold port. In one embodiment, the second end of the drainage catheter is securable to the drainage manifold port for connecting the drainage catheter to the drainage manifold.

[0041] In one embodiment, the drainage conduit preferably includes a one-way check valve configured to allow fluid passing through the drainage conduit to move in only one direction toward the drainage chamber of the injection port assembly.

[0042] In one embodiment, the drainage manifold has an inner face and an outer face. In one embodiment, the drainage manifold port protrudes from the inner face of the drainage manifold, and the outer face of the drainage manifold is fixed to the inner surface of the housing to form a watertight seal between the drainage manifold and the inner surface of the housing.

[0043] In one embodiment, the inner face of the drainage manifold surrounds the slot. In one embodiment, the tissue expander includes one or more drainage tubes disposed in the slot and aligned with one or more drainage holes formed in the housing. In one embodiment, the drainage manifold port is in fluid communication with the slot and the one or more drainage tubes disposed in the slot.

[0044] In one embodiment, the tissue expander can include a drainage manifold having an inner face and an outer face, the outer face of the drainage manifold forming a water-tight seal with the inner surface of the housing and surrounding one or more drainage openings formed in the housing.

[0045] In one embodiment, the integrated drainage tube includes a sealed drainage cap secured to an inner surface of the drainage manifold. In one embodiment, the second end of the drainage conduit is preferably coupled to the drainage manifold.

[0046] In one embodiment, the tissue expander can include an infusion chamber covering a top surface of a barrier membrane, whereby the barrier membrane separates the infusion chamber from the drainage chamber.

[0047] In one embodiment, the infusion conduit is in fluid communication with and extends between the infusion chamber and at least one of the one or more drainage holes formed in the housing for delivering the infusion fluid to the exterior of the housing.

[0048] In one embodiment, a tissue expander with an integrated drainage tube preferably includes a shell and an injection port assembly, the shell having an injection port opening and one or more drainage holes formed in the shell, the injection port assembly being disposed in the injection port opening to form a fluid-tight seal with the shell and including a needle guard having a needle guard base with a top surface.

[0049] In one embodiment, the barrier film is disposed within the needle guard and covers the top surface of the needle guard base.

[0050] In one embodiment, the barrier membrane defines an inflation chamber located between a top surface of the needle guard base and a bottom surface of the barrier membrane for inflating and deflating the housing with the first fluid.

[0051] In one embodiment, the barrier membrane defines a drainage chamber located within the needle guard and covering a top surface of the barrier membrane for draining the second fluid from outside the housing through the one or more drainage holes.

[0052] In one embodiment, the needle assembly is preferably configured for insertion into an injection port assembly. In one embodiment, the needle assembly has a first configuration in which the inflation lumen of the needle assembly is in fluid communication with the inflation chamber to selectively inflate and deflate the housing using a first fluid, and a second configuration in which the drainage lumen of the needle assembly is in fluid communication with the drainage chamber for draining a second fluid from outside the housing.

[0053] In one embodiment, the barrier membrane support protrudes from the top surface of the needle guard base toward the bottom surface of the barrier membrane for supporting the underside of the barrier membrane.

[0054] In one embodiment, the needle guard preferably includes a needle guard edge extending upwardly from the needle guard base.

[0055] In one embodiment, the injection port assembly preferably includes an injection dome secured to the upper end of the needle guard rim. In one embodiment, the injection dome preferably includes a base having a bottom surface with an annular groove formed therein, whereby the upper end of the needle guard rim is disposed within the annular groove of the injection dome for securing the injection dome to the needle guard.

[0056] In one embodiment, the needle guard edge has one or more component openings (eg, elongated slots) formed therein, the component openings being located adjacent the upper end of the needle guard edge.

[0057] In one embodiment, the one or more assembly openings are disposed within an annular groove of the injection dome.

[0058] In one embodiment, the silicone material covers the upper end of the needle guard rim and contacts one or more component openings formed in the needle guard rim.

[0059] In one embodiment, a silicone material preferably secures the injection dome to the upper end of the needle guard rim.

[0060] Dip molding using a mandrel of appropriate size and shape can be used to form the shell, but other suitable methods such as injection molding or spraying can also be used. By dip molding, the mandrel is dipped into a silicone dispersion and then removed to allow partial curing and solvent evaporation. This process is usually repeated several times. Once the shell is formed, it is removed from the mandrel. The dip molding process forms a partial shell with an opening (e.g., a circular hole (patch hole)) on the back side. An injection port is installed, and the patch hole is then covered with a patch that seals the hole, thereby forming a complete fluid-impermeable shell. Silicone rubber or other similar biocompatible adhesives can be used to attach the patch to the partial shell. The complete shell can be unfilled or partially pre-filled. After the expander is implanted, the expander is filled with saline, gel, foam, or a combination of these materials or other suitable materials known in the art during surgery through the injection port to gradually increase the tissue expander to the desired size. Filling is usually performed through the injection port during multiple office visits.

[0061] These and other preferred embodiments of the invention are described in more detail below. BRIEF DESCRIPTION OF THE DRAWINGS

[0062] Figure 1A A perspective view of a tissue expander with an integrated drainage system according to one embodiment of the present patent application is shown.

[0063] Figure 1B Shows Figure 1A A side view of a tissue expander is shown.

[0064] Figure 2 A cross-sectional view of a tissue expander with an integrated drainage system according to one embodiment of the present patent application is shown.

[0065] Figure 3 Shows Figure 2 An enlarged view of the injection port of a tissue expander is shown.

[0066] Figure 4A Shows Figure 1A and Figure 1B A partial cross-sectional side view of a tissue expander is shown.

[0067] Figure 4B Shows Figure 1A and Figure 1B A partial cross-sectional top view of a tissue expander is shown.

[0068] Figure 5A The inner surface of the drainage manifold of the integrated drainage system of the tissue expander according to one embodiment of the present patent application is shown.

[0069] Figure 5B Shows Figure 5A The exterior surface of the drainage manifold is shown.

[0070] Fig. 6A According to one embodiment of the present patent application, Figure 5A and Figure 5B A perspective view of the drainage manifold assembled together with the drainage tubes.

[0071] Figure 6B Shows Fig. 6A A cross-sectional view of the drainage tube is shown.

[0072] Figure 7 A method of inflating a tissue expander according to one embodiment of the present patent application is shown.

[0073] Fig. 8A A method of draining a tissue expander having an injection port and an integrated drainage system according to one embodiment of the present patent application is shown.

[0074] Figure 8B Shows Fig. 8A An enlarged view of the injection port of a tissue expander is shown.

[0075] Fig. 9 A cross-sectional view of a tissue expander with an integrated drainage tube according to one embodiment of the present patent application is shown.

[0076] Fig. 10A A partial cross-sectional view of a tissue expander with an integrated drainage and infusion system according to one embodiment of the present patent application is shown.

[0077] Fig. 10B Shows Fig. 10A A side view of a tissue expander is shown.

[0078] Fig. 10C Shows Fig. 10A and Fig. 10B A cross-sectional side view of a tissue expander is shown.

[0079] Fig.11 An embodiment of the present patent application is shown. FIG. 10A to FIG. 10C The drainage catheter of the tissue expander is shown.

[0080] Fig.12 An embodiment of the present patent application is shown. FIG. 10A to FIG. 10C An infusion catheter for a tissue expander is shown.

[0081] Fig.13 An injection port of a tissue expander according to one embodiment of the present patent application is shown, the injection port having a movable membrane coupled to a magnetic element.

[0082] Fig.14A According to one embodiment of the present patent application, the use Fig.13 The injection port is the first step in the method of draining fluid from around the periphery of the tissue expander.

[0083] Fig. 14B According to one embodiment of the present patent application, the use Fig.13 The injection port is a second step of the method for draining fluid from around the periphery of the tissue expander.

[0084] Fig.15A A top view of a tissue expander with an integrated drainage system including drainage holes disposed on the top side of the housing according to one embodiment of the present patent application is shown.

[0085] Fig. 15B Shows Fig.15A A side perspective view of a tissue expander is shown.

[0086] Fig.16A A top perspective view of a tissue expander having an integrated drainage system including radially extending drainage holes according to one embodiment of the present patent application is shown.

[0087] Fig. 16B Shows Fig.16A A side view of a tissue expander is shown.

[0088] Fig.17 A schematic diagram of a tissue expander with an integrated drainage system according to one embodiment of the present patent application is shown.

[0089] Fig.18 A schematic diagram of a tissue expander according to one embodiment of the present patent application is shown, the tissue expander having an integrated system for drainage and infusion of fluids.

[0090] Fig.19 A schematic diagram of a tissue expander with an integrated inflation, drainage and infusion system according to one embodiment of the present patent application is shown.

[0091] Fig. 20 A tissue expander according to one embodiment of the present patent application is shown having a first injection port for drainage and infusion of fluid and a second injection port for inflating the tissue expander with a solution.

[0092] Fig.21 A system for creating a vacuum to drain fluid collected around a tissue expander according to one embodiment of the present patent application is shown.

[0093] Fig.22A An embodiment of the present patent application is shown. Figure 5A and Figure 5B A perspective view of the drainage manifold assembled together with the drainage tubes.

[0094] Fig. 22B Shows Fig.22A A cross-sectional view of the drainage tube is shown.

[0095] Fig.23A is a perspective view of an injection port assembly including a needle guard and an injection dome according to one embodiment of the present patent application.

[0096] Fig. 23B yes Fig.23A Side elevation view of the needle guard and injection dome shown.

[0097] Fig.24A According to one embodiment of the present patent application Fig.23A and Fig. 23B A perspective view of the top side of the needle guard is shown.

[0098] Fig. 24B yes Fig.24A Another perspective view of the needle guard is shown.

[0099] Fig.24C yes Fig.24A and Fig. 24B Top plan view of the needle guard shown.

[0100] Fig.24D yes Figure 24A-24C A cross-sectional view of the needle guard shown.

[0101] Fig.25A yes Fig.23A and Fig. 23B A side elevation view of the injection dome is shown.

[0102] Fig.25B yes Fig.25A A perspective view of the underside of the injection dome is shown.

[0103] Fig.25C yes Fig.25A and Fig.25B A partial cross-sectional view of the injection dome is shown.

[0104] Fig.26 According to one embodiment of the present patent application, 25A- Fig.25C The injection dome with Figure 24A-Figure 24D A method of assembling the needle guard together.

[0105] Fig. 27 It is assembled together Fig.26 Cross-sectional view of the injection dome and needle guard.

[0106] Fig.28 is a perspective view of a first anvil and a second anvil for securing an injection dome to a needle guard according to one embodiment of the present patent application.

[0107] Fig.29 According to one embodiment of the present patent application Fig.28 A perspective view of a first anvil and a second anvil during stages of a method of securing an injection dome to a needle guard.

[0108] Fig.30 is a cross-sectional view of an injection port assembly according to one embodiment of the present patent application, the injection port assembly comprising a needle guard, a barrier membrane, an injection dome and a needle assembly, the needle assembly comprising a needle and an insert disposed inside the needle.

[0109] Fig.31A yes Fig.30 Side view of the needle shown.

[0110] Fig.31B yes Fig.31A A distal end view of the elongated shaft of the needle is shown.

[0111] Fig.31C yes Fig.31A and Fig.31B A cross-sectional view of the distal end of the elongated shaft of the needle is shown.

[0112] Fig.32A yes Fig.30 A side elevation view of the insert is shown.

[0113] Fig.32B yes Fig.32A A distal end view of the insert is shown.

[0114] Fig.33 According to one embodiment of the present patent application Fig.30 A cross-sectional view of a needle assembly is shown, the needle assembly comprising Figure 31A-Figure 31C The needle, Figure 32A-32B The insert is disposed within the needle and is in an extended position.

[0115] Fig.34 According to one embodiment of the present patent application Fig.33 A cross-sectional view of the distal end of the needle and the inserter with the inserter in a retracted position.

[0116] Fig.35A According to one embodiment of the present patent application Fig.30 A cross-sectional view of an injection port assembly of FIG. 1 , wherein the distal end of the needle assembly is inserted into the inflation chamber of the injection port assembly.

[0117] Fig.35B It is inserted into the injection chamber of the injection port assembly. Fig.35A An enlarged view of the distal end of the needle assembly is shown.

[0118] Fig.36 According to one embodiment of the present patent application Fig.30 A cross-sectional view of an injection port assembly and a needle assembly with the insert in a retracted position.

[0119] Fig.37A According to one embodiment of the present patent application Fig.36 Magnified view of the injection port assembly and needle assembly with the insert in the retracted position.

[0120] Fig.37B According to one embodiment of the present patent application Fig.37A An enlarged view of the distal end of the needle assembly with the insert in a retracted position to align with the drainage chamber of the injection port assembly.

[0121] Fig.38 is a cross-sectional view of a barrier film support for an injection dome assembly according to one embodiment of the present patent application, the barrier film support being adapted to receive an inner barrier film and an outer barrier film.

[0122] Fig.39 yes Fig.38 A cross-sectional view of a barrier film support, an inner barrier film and an outer barrier film.

[0123] Fig.40 According to one embodiment of the present patent application, Fig.38 The stages of a method of assembling a barrier film support and a needle guard together.

[0124] Fig.41 According to one embodiment of the present patent application, after the barrier film support has been fixed with the needle guard Fig.40 A cross-sectional view of a barrier membrane support and a needle guard.

[0125] Fig.42 is a schematic diagram of a tissue expander according to one embodiment of the present patent application, the tissue expander having two expansion zones separated from each other and a multi-compartment injection dome assembly. DETAILED DESCRIPTION

[0126] In one embodiment, see Figure 1A and Figure 1B , tissue expander 100 preferably includes a housing 102 and an injection port 104 located on the top side of the housing. Housing 102 may have any desired shape and any thickness suitable for the purpose of a particular tissue expander. Housing 100 may be formed of a biocompatible elastomeric material such as silicone.

[0127] In one embodiment, the tissue expander 100 preferably includes one or more stabilizing tabs 106 that can be used to secure the tissue expander 100 to the tissue. In one embodiment, sutures or surgical fasteners can be used to secure the one or more stabilizing tabs 106 to the patient's tissue. In one embodiment, the tissue expander 100 advantageously includes one or more drainage holes 108 disposed on the housing 102. The one or more drainage holes 108 can be used to drain fluid (e.g., seroma fluid) that may accumulate around the tissue expander 100 after surgical implantation.

[0128] In one embodiment, see Figure 2 and Figure 3 , the injection port 104 can be fixed to the opening present in the housing for sealing the housing 102. In one embodiment, the injection port 104 is assembled in the opening of the housing 102 at a position facing the patient's skin surface. The injection port can be formed of an elastomeric material. In one embodiment, the injection port 104 advantageously includes a septum area 110, which is preferably located at a central area of ​​the upper surface of the injection port 104 and / or the tissue expander 100. The septum area 110 is advantageously self-sealing to prevent fluid from leaking from the tissue expander 100 after the injection needle is removed from the injection port 104.

[0129] In one embodiment, the injection port 104 advantageously includes an outer flange 112 that overhangs the outer surface of the housing 102. In one embodiment, the injection port 104 advantageously includes a self-sealing safety patch 114 secured to the inner surface of the housing 102, whereby the housing is at least partially sandwiched between the flange 112 of the injection port and the self-sealing safety patch 114. The self-sealing safety patch preferably has a diameter greater than the flange 112 of the injection port 104, such that the safety patch extends beyond the outer perimeter of the flange 112.

[0130] In one embodiment, a mandrel of appropriate size and shape can be used to form the shell 102 of the tissue expander 100. In one embodiment, the shell 102 can be formed using a dip molding method, but other methods can also be used, including spraying the mandrel with a solution that forms the shell or injection molding. In the dip molding method, the mandrel is dipped into a silicone dispersion and then removed to allow partial curing and solvent evaporation. This dipping step is repeated several times. Once the shell is formed, it is removed from the mandrel. The dip molding process forms a partial shell with an opening (e.g., a circular hole (patch hole)). The injection port 104 and the safety patch 114 are installed to form a complete fluid-impermeable shell. The safety patch 114 can be attached to the inner surface of the shell 102 using silicone rubber or other similar biocompatible adhesives. The complete shell can be unfilled or partially pre-filled. After implantation of the tissue expander, the tissue expander 100 is filled with saline, gel, foam, or a combination of these materials or other suitable materials known in the art across the septal region 110 to gradually enlarge the tissue expander 100 to the desired size. This typically occurs over the course of multiple office visits.

[0131] In one embodiment, the injection port 104 advantageously includes a needle guard 116 having a needle guard base 118 and a needle guard edge 120 extending upwardly from the needle guard base 118. In one embodiment, the needle guard edge 120 completely surrounds the outer periphery of the needle guard base 118.

[0132] In one embodiment, the injection port 104 desirably includes a barrier film 122 that extends from one side of the needle guard edge 120 to an opposite side of the needle guard edge portion 120. In one embodiment, the barrier film 122 preferably covers the needle guard base 118 and is coextensive with a region of the needle guard base 118. The barrier member 122 preferably divides the injection port 104 into an inflation chamber 124 for introducing inflation solution into the housing 102 to expand the tissue expander and / or removing solution from the housing to deflate the tissue expander, and a drainage chamber 126 for draining fluid (e.g., seroma fluid) that may accumulate around the housing 102 of the tissue expander 100 after the tissue expander is implanted.

[0133] In one embodiment, the inflation chamber 124 is in fluid communication with the housing inflation ports 128A, 128B which pass through lateral openings provided in the needle guard edge 120. In one embodiment, an injection needle can be used to introduce a fluid (e.g., a saline solution) into the inflation chamber 124, which then flows through the inflation ports 128A, 128B for inflating the housing 102 with the solution. In one embodiment, an injection needle can be used to create a vacuum within the inflation chamber while removing fluid from the housing 102 to deflate the tissue expander 100.

[0134] In one embodiment, the drainage chamber 126 of the injection port 104 preferably includes a drainage port 130 that passes through an opening 132 formed in the needle guard edge 120 of the needle guard 116. In turn, the drainage port 130 is connected to a first end 134 of a drainage conduit 136. The drainage conduit 136 advantageously has a second end 138 coupled to the drainage tube 140, which is in fluid communication with one or more drainage holes 108 formed in the housing 102.

[0135] In one embodiment, the first needle 142 is used to inflate and deflate the housing 102 of the tissue expander 100. The first needle 142 preferably has a sharp tip 144 and an opening 146 disposed at the sharp tip 144. In one embodiment, the sharp tip 144 of the first needle 142 passes through the septum 110 and the barrier membrane 122 such that the opening 146 at the distal tip 144 of the first needle 142 is aligned with the inflation chamber 124 of the injection port 104. Once the opening 146 of the first needle 142 is positioned within the inflation chamber 124, a fluid (e.g., saline solution) may pass through the needle opening 146, and the injected fluid subsequently flows into the inflation chamber 124, through the lateral openings in the needle guard edge 120, and through the inflation ports 128A, 128B for inflation of the housing 52 with the injected fluid. To deflate tissue expander 100 , fluid may be removed from housing 102 using first needle 142 by withdrawing fluid through inflation ports 128A, 128B and into inflation chamber 124 , after which the fluid may be removed from housing 102 via first needle 142 .

[0136] In one embodiment, the second needle 148 can be used to drain fluid that has collected around the outer periphery of the tissue expander 100. In one embodiment, the second needle 148 has a sharp distal tip 150 and a side port 152 spaced proximally from the sharp distal tip 150. As will be described in greater detail herein, the side port 152 of the second needle enables fluid that has collected around the exterior of the housing to be drained and removed from the patient.

[0137] In one embodiment, see Figure 4A and Figure 4B The tissue expander 100 preferably includes a drainage manifold 154 that is aligned with and covers one or more drainage holes 108 disposed on the housing 102. In one embodiment, the second end 138 of the drainage conduit 136 is fixed to the drainage manifold port 156 for connecting the drainage conduit 136 to the drainage manifold 154.

[0138] In one embodiment, the drainage catheter 136 advantageously includes a one-way check valve 158 ( Figure 2 ), which allows fluid passing through the drainage conduit to move in only one direction designated as DIR1, i.e., toward the drainage chamber 126 ( Figure 3 )move.

[0139] In one embodiment, see Figure 5A and Figure 5B , the drainage manifold 154 advantageously includes a drainage manifold port 156 protruding from an inner surface 158 of the drainage manifold 154. In one embodiment, the drainage manifold 154 preferably has an outer surface 160 surrounding a groove 162 that is suitable for receiving one or more drainage tubes 140 ( Figure 2 ), the one or more drainage tubes are preferably connected to one or more drainage holes 108 ( Figure 1A ) is aligned. The drainage manifold port 156 is advantageously in fluid communication with a groove 162 disposed at a front face 160 of the drainage manifold 154. In one embodiment, the outer surface 160 of the drainage manifold 154 is preferably fixed to the inner surface ( Figure 1A ) to form a watertight seal with the inner surface of the shell to separate the fluid used to inflate and deflate the shell from the fluid drained from the outside of the shell.

[0140] In one embodiment, one or more drainage tubes 140 ( Figure 2 ) is advantageously positioned within the groove 162 of the drainage manifold 154 to drain fluid from around the periphery of the tissue expander. In one embodiment, the drainage tube is advantageously connected to the drainage hole 108 ( Figure 1A ) to align.

[0141] In one embodiment, see Fig. 6A and Figure 6B , the drainage tube 140 preferably has a core 166 with struts 168 that protrude from the core 166 along the longitudinal axis of the core. Each of the outer ends of the struts 168 has a corresponding overhang 170 that extends longitudinally throughout the entire length of the strut 168. In one embodiment, as Figure 6BAs shown, the overhangs 170 are arcuate members extending on either side of their respective struts 168. The overhangs 170 are sized to form a generally elliptical member at the perimeter of the drain tube 140 with small gaps between adjacent overhangs 170. Each of these gaps forms a longitudinal groove 172 that is parallel to the longitudinal axis of the core 166 and extends throughout the entire length of the drain tube 140. The core portion 166, struts 168, and overhangs 170 combine to form a plurality of channels or lumens 174 extending along the length of the drain tube 140. The longitudinal grooves 172 allow fluid communication between the respective lumens 174 and the wound.

[0142] In one embodiment, the drain 140 can be similar to the surgical drains disclosed in US Pat. No. 4,398,910 to Blake et al., the disclosure of which is hereby incorporated herein by reference.

[0143] In one embodiment, see Figure 7 To inflate the tissue expander 100, the sharp distal tip 144 of the first needle 142 passes through both the septum region 110 and the barrier membrane 122 of the injection port 104 until the opening 146 at the distal tip 144 of the inflation needle 142 is aligned with the inflation chamber 124 of the injection port. In one embodiment, a fluid (e.g., saline solution) is injected from the opening 146 at the distal tip 144 of the first needle 142, and the injected fluid then flows into the inflation chamber 124 and through the inflation ports 128A, 128B to inflate the housing 102 and expand the tissue expander 100. The distal tip 144 is advantageously stopped by the needle guard base 118 of the needle guard 116 to prevent the distal tip of the first needle from passing through the bottom of the injection port 104 and / or damaging the housing of the tissue expander. If the opening 146 at the distal end 144 of the first needle 142 is not properly aligned with the drainage chamber 126 of the injection port 104 and fluid is injected under pressure from the opening 146 of the first needle 142, the one-way check valve 158 ( Figure 2 ) will prevent fluid from passing through the drainage catheter and reaching the drainage tube 140 located at the second end 138 of the drainage catheter 136.

[0144] In one embodiment, see Fig. 8A and Figure 8B The body fluid collected around the shell 102 of the tissue expander 100 can be drained from one or more drainage openings 108 ( Figure 1A ) drainage. In one embodiment, the second needle 148 ( Figure 3) is used to drain fluid that has accumulated around the outer periphery of the housing 102. In one embodiment, the sharp distal tip 150 of the second needle 148 is advanced through the barrier membrane 122 until the sharp tip 150 abuts the top surface of the needle guard base 118 of the needle guard 116. When the sharp distal tip 150 of the second needle 148 engages the needle guard base 118, the side port 152 of the second needle 148 (which is spaced apart from the distal tip 150) is preferably aligned with the drainage chamber 126 of the injection port 104 covering the top surface of the barrier membrane 122. A vacuum can then be drawn through the second needle 148 for withdrawing fluid (e.g., a seroma) through the drainage conduit 136. The drainage conduit 136 preferably includes a one-way check valve 158 that enables the accumulated fluid to flow in only one direction (e.g., toward the injection port 104). The drained fluid preferably passes through the one-way check valve 158 , through the drainage port 130 , and into the drainage chamber 126 where the fluid is withdrawn through the side port 152 of the drainage needle 148 . Figure 8B The flow of the drained fluid is shown, where the drained fluid flows through the one-way check valve 158 , the first end 134 of the drainage conduit 136 , and the drainage chamber 126 and into the side port 152 of the second needle 148 to be removed from the housing 102 of the tissue expander 102 .

[0145] In one embodiment, see Fig. 9 , the tissue expander 200 has an integrated drainage tube disposed therein for draining fluid and / or liquid accumulated around the periphery of the housing 202 of the tissue expander. In one embodiment, the tissue expander 200 preferably includes a drainage conduit 236 having a first end 234 coupled to the drainage port 230 of the injection port 204 and a second end 238 coupled to a drainage manifold 254, which is positioned adjacent to the drainage opening 208 disposed on the housing 202. In one embodiment, the integrated drainage tube does not include the above-mentioned Fig. 6A and Figure 6B Drainage tube 140 ( Fig. 6A ). In contrast, the integrated drainage tube includes a sealed drainage cap 245 secured to an inner surface 258 of the drainage manifold 254. An outer surface 260 of the drainage manifold 254 is preferably secured to the inner surface 255 of the housing 202 to form a watertight seal between the inner surface of the housing and the outer surface of the drainage manifold 254 for separating the inflation fluid circulating within the housing 202 from the liquid that accumulates around the housing 202 and is drained through the one or more drainage holes 208.

[0146] In one embodiment, see FIG. 10A to FIG. 10C, the tissue expander 300 preferably includes a housing 302, an injection port 304, a stabilizing tab 306, and a drainage and infusion port 308 disposed on the housing 302. In one embodiment, the tissue expander 300 advantageously includes a manifold 354, which is preferably used for both drainage and infusion and is positioned inside the housing 302 adjacent to the drainage and infusion port 308. In one embodiment, a drainage conduit 336A has a first end 334A coupled to the drainage and infusion chamber 326 of the injection port 304, and a second end 338A coupled to the drainage port 356A of the manifold 354. As will be described in more detail herein, the drainage conduit 336A advantageously includes a one-way check valve 358A that allows fluid drained through the hole 308 to flow from the second end 338A of the drainage conduit 336A to the first end 334A, but does not allow fluid to flow in the opposite direction from the first end 334A of the drainage conduit 336A to the second end 338A.

[0147] In one embodiment, the tissue expander 300 desirably includes an infusion conduit 336B having a first end 334B coupled to the drainage and infusion chamber 325 of the injection port 304 and a second end 338B coupled to an infusion port 356B disposed on the manifold 354. In one embodiment, a solution (e.g., a medical solution, an antibiotic) may pass through the infusion conduit 336B to be dispensed from the hole 308 formed in the housing 252. In one embodiment, the infusion conduit 336B desirably includes a one-way check valve 358B that allows the infusion solution to flow from the first end 334B of the infusion conduit 336B to the second end 338B of the infusion conduit 336B, but does not allow flow through the infusion conduit 336B in the opposite direction.

[0148] In one embodiment, see Fig. 10C and Fig.11 , the tissue expander 300 advantageously includes a drainage conduit 336A having a one-way check valve 358A that allows the drained fluid to flow from the second end 338A of the drainage conduit 336A to the first end 334A in a direction designed as DIR1, but not in an opposite direction designed as DIR2. In one embodiment, the manifold 354 is fixed to the second end 338A of the drainage conduit 336A. The drainage system advantageously includes one or more drainage tubes 340 located within the groove 362 of the manifold 354 and located between the opening at the second end 338A of the drainage conduit 336A and the one or more holes 308 formed in the housing 302. The fluid drained through the one or more holes 308 passes through the one or more drainage tubes 340 and enters the drainage conduit 336A.

[0149] Fig.12A one-way check valve 358B is shown disposed in the infusion conduit 336B. The one-way check valve 358B allows infusion fluid to flow from the first end 284B to the second end 288B of the infusion conduit 286B in only one direction, designated DIR2, and not in the opposite direction, designated DIR1.

[0150] In one embodiment, see Fig.13 , the injection port 404 of the tissue expander 400 advantageously includes a movable barrier membrane 422 positioned inside a needle guard 416 having a needle guard base 418 and a needle guard edge 420 protruding upwardly from the needle guard base 418. The injection port 404 preferably includes a magnet 475 positioned on top of a compressible spring 485 that normally forces the movable barrier membrane 422 into the needle guard. Fig.13 In one embodiment, the movable barrier film 422 advantageously includes a film edge 425 that is configured to extend when the movable barrier film 422 is in the extended position. Fig.13 In the extended position shown, the edge of the membrane blocks the drain port 430. In one embodiment, the magnet 475 and the movable barrier membrane 422 are connected together and together in Fig.13 The extended position shown is Fig. 14B Move between the compressed positions shown.

[0151] In one embodiment, to inflate the housing of the tissue expander with a solution, an inflation needle 442 having a distal tip 444 with an opening 446 is preferably passed through the dome 410 of the injection port 404 until the distal tip 444 of the needle 442 abuts against the top surface of the needle guard base 418 of the needle guard 416. The compression spring 485 is extended so that the magnet 475 and the movable barrier membrane 422 are in an extended position. When the solution is injected from the opening 446 at the distal tip 444 of the needle 442, the injected solution advantageously flows through the opening 435 in the bottom plate of the barrier membrane 422 and flows through the inflation port 428 for filling the housing of the tissue expander 400.

[0152] In one embodiment, see Fig.14A , the second magnet 495 can be positioned above the elongated shaft of the injection needle 442. The second magnet 495 can be positioned adjacent to the lower end of the syringe. The second magnet 495 preferably generates a magnetic field that repels the first magnet 475 located inside the injection port 440. The repulsive force between the magnet 475 and the magnet 495 moves the movable barrier membrane 422 to Fig.14A In the compressed position shown, the barrier edge 422 of the barrier membrane 422 is then positioned below the opening of the drainage port 430 so that fluid that has accumulated around the periphery of the tissue expander can be drawn out through the drainage port. Fig.14AA dashed line P is shown indicating a possible insertion path of the needle 442 when the needle is inserted into the injection port 404 .

[0153] See also Fig. 14B , the second magnet 495 around the injection needle 442 repels the first magnet 475 in the injection port 404 to compress the spring 485 and move the movable barrier film 422 to the compressed position. The peripheral edge 425 of the movable barrier film 422 no longer blocks the drainage port 430, so that the drainage fluid can be drawn into the opening 446 at the sharp end 444 of the injection needle 442. When the movable barrier film 422 moves to Fig. 14B In the lower compressed position shown, the compression spring 485 coupled to the lower side of the first magnet 475 is compressed. When the second magnet 495 moves away from the injection port 404, the energy stored in the compression spring 485 will return the movable barrier film 422 to the Fig.13 When the movable barrier film 422 returns to the extended position Fig.13 In the extended position shown, the peripheral edge 425 of the movable barrier membrane 422 again blocks the drainage port 430 of the injection port 404 of the tissue expander 400 .

[0154] In one embodiment, see Fig.15A , Fig. 15B , tissue expander 500 advantageously includes a housing 502 and an injection port 504. Tissue expander 500 advantageously includes a plurality of holes 508 formed in the top side of housing 502. A series of holes 508 can be used to drain fluids that accumulate around the exterior of housing 502 and / or infuse a medical solution through holes 508 and around the exterior of housing 502. In one embodiment, tissue expander 500 may include one or more drainage conduits and drainage tubes as disclosed herein. In one embodiment, tissue expander 500 may include one or more infusion conduits as disclosed herein. In one embodiment, tissue expander 500 may include a drainage conduit in communication with one or more of holes 508 and an infusion conduit in communication with one or more of holes 508.

[0155] In one embodiment, see Fig.16A and Fig. 16B , tissue expander 600 advantageously includes a housing 602 and an injection port 604. Tissue expander 600 advantageously includes a series of radially extending holes 608 that can be used to drain fluid that has accumulated around the exterior of housing 602 and / or to infuse fluid from the holes to flow around the exterior of housing 602.

[0156] In one embodiment, see Fig.17, the tissue expander 700 preferably includes a housing 702 and an injection port 704 positioned in an opening of the housing 702. In one embodiment, the housing 702 preferably has a drainage opening 708 formed therein, and a drainage conduit 736 extending between the drainage opening 708 and the injection port 704.

[0157] In one embodiment, the injection port 704 preferably includes an injection compartment 755. A first one-way check valve 758A is positioned between the first end 734 of the drainage conduit 736 and the injection compartment 755. Under vacuum, the first one-way check valve 758A opens to allow fluid to be drawn into the injection compartment 755, such as by using the needle 742. Under pressure, the first one-way check valve 758A remains closed.

[0158] In one embodiment, tissue expander 700 preferably includes a second one-way check valve 758B that enables an inflation fluid (e.g., saline solution) to be introduced into injection compartment 755 and flow through second one-way check valve 758B into the interior of housing 702 to inflate tissue expander 700. Second one-way check valve 758B opens under pressure and remains closed under vacuum. Thus, first one-way check valve 758A opens under vacuum and second one-way check valve 758B opens under pressure, such that first one-way check valve 758A and second one-way check valve 758B are not opened at the same time. In one embodiment, the same syringe / needle 742 can be used to deliver inflation fluid into injection compartment 755 in a forward stroke and to discharge drainage fluid from injection compartment 755 in a reverse stroke.

[0159] In one embodiment, the injection port 704 of the tissue expander 700 desirably includes a third one-way check valve 758C located between the injection compartment 755 and the interior area of ​​the housing 702. The third one-way check valve 758C desirably opens under vacuum, but has a highly restricted orifice 765 so that the third one-way check valve 758C under vacuum will cause some saline to drain back into the injection compartment 755 for flushing the compartment and also causing the tissue expander 700 to collapse.

[0160] In one embodiment, see Fig.18 , the tissue expander 750 advantageously includes a housing 802 and an injection port 804. The injection port 804 advantageously includes a first injection chamber 855A communicating with a first check valve 858A and a second check valve 858B and a second injection chamber 855B communicating with a third check valve 858C. The membrane 865 separates the first injection chamber 855A from the second injection chamber 855B. The distal end of the injection needle 852 can pass through the membrane to enter the second injection chamber 855B to inject fluid into the second injection chamber 855B or remove fluid from the second injection chamber 855B.

[0161] In one embodiment, the first check valve 858A is coupled to a drainage conduit 836A that is in communication with a drainage opening 808A formed in the housing 802. The second check valve 858B is advantageously in communication with an infusion conduit 836B that is coupled with an infusion opening 808B formed in the housing 802 of the tissue expander 800. Under vacuum, the first one-way check valve 858A opens in the first injection chamber 855A to drain fluid accumulated around the tissue expander through the drainage opening 808A and the drainage conduit 836A. The drained fluid can be removed from the first injection chamber 855A using a needle 842. Under pressure, the second one-way check valve 858B opens in the first injection compartment 855A to allow infusion fluid to pass through the infusion conduit 836B to the infusion opening 808B. In one embodiment, therefore, the same syringe 842 can be used to deliver fluid (e.g., antibiotic solution) via infusion conduit 836B during a forward stroke and can be used to discharge drainage fluid (e.g., seroma) via drainage conduit 836A and drainage opening 808A during a reverse stroke.

[0162] In one embodiment, the third valve 858C is located in the second injection chamber 855B. The third valve 858C can be used to inflate and deflate the housing 802 of the tissue expander 800. Under pressure, the fluid in the second injection chamber 855B passes through the third valve 858C to inflate the housing 802. Under vacuum, the fluid in the housing 802 is drawn through the third valve 858C into the second injection chamber 855B, where the fluid can be drawn using the needle 842.

[0163] In one embodiment, see Fig.19 , the tissue expander 900 includes a housing 902 having an injection port 904. The injection port advantageously includes a first injection chamber 955A in communication with the drainage catheter 936A and a second injection chamber 955B in communication with the infusion tube 936B. In one embodiment, a first membrane 965A separates the first injection chamber 955A and the second injection chamber 955B from each other. In one embodiment, the injection port 904 may include an injection area marker for locating and distinguishing the first injection chamber 955A and the second injection chamber 955B, as disclosed in the commonly assigned U.S. Patent 9,636,210 to Hristov et al., the disclosure of which is hereby incorporated herein by reference. The injection area marker may be made of a material having an ultrasonically detectable marker incorporated therein. In one embodiment, the marker may include a plurality of microcavities positioned relative to the first and second injection chambers of the injection port so that when detected ultrasonically, such detection includes the location of the first and second injection chambers.

[0164] The tissue expander 900 advantageously includes a first check valve 958A coupled to a first end of the drainage conduit 936A. The drainage conduit 936A is in turn coupled to a drainage hole 908A disposed in the housing 902. Under vacuum within the first injection chamber 955A, the first check valve 958A opens to allow fluid to be drawn through the drainage opening 908A, the drainage conduit 936A, and the first one-way check valve 958A into the first injection chamber 885A to draw fluid from the first injection chamber using the needle 892.

[0165] The second check valve 958B is disposed at a first end of the infusion conduit 936B. The infusion conduit 936B has a second end coupled to an infusion hole 908B formed in the housing 902. Under the pressure in the second injection chamber 955B, the second one-way check valve 958B opens to allow the fluid injected into the second injection chamber 955B to pass through the second valve 908B, through the infusion conduit 936B and out of the infusion hole 908B to infuse the fluid to the outer surface of the housing.

[0166] In one embodiment, the third injection chamber 955C can be used to introduce fluid into the housing 852 to expand the size of the tissue expander or to withdraw fluid from the housing 902 to reduce the size of the tissue expander 900 (i.e., shrink). In one embodiment, the tissue expander 900 advantageously includes a third valve 958C coupled to the third injection chamber 955C. The second membrane 965B separates the first injection chamber 955A and the second injection chamber 955B from the third injection chamber 955C. The needle 942 can pass through the first and second membranes for selective access to each of the injection chambers 955A to the injection chamber 955C. Under pressure, the third check valve 908C opens to allow a solution, such as a saline solution, to flow through the valve 908C and into the housing 902 to inflate the tissue expander 900. Under vacuum, the third check valve 958C opens to withdraw fluid from the housing 902 into the third injection chamber 955C to reduce the size of the tissue expander.

[0167] In one embodiment, see Fig. 20, the tissue expander 1000 advantageously includes a housing 1002 having a first injection port 1004A and a second injection port 1004B fixed to the housing 1002. In one embodiment, the first injection port 1004A includes a first injection chamber 1055A in communication with a first check valve 1058A and a second check valve 1058B. In one embodiment, the tissue expander 1000 includes a first drainage conduit 1036A having a first end coupled to a drainage port in communication with the first check valve 1058A. The drainage conduit 1036A preferably includes a second end coupled to a drainage hole 1008A formed in the housing 1002 of the tissue expander 1000. In one embodiment, when a vacuum is drawn inside the first injection chamber 1055A, the first check valve 1058A opens to allow any fluid that has accumulated around the exterior of the tissue expander 1000 to be drawn out through the drainage holes 1008A, through the drainage conduit 1036A, through the open first check valve 1058A and into the first injection chamber to draw the fluid out of the first injection chamber 1055A using the needle 1042.

[0168] In one embodiment, the second check valve 1058B is disposed between the first injection chamber 1055A and the first end of the infusion conduit 1036B. The infusion conduit 1036B has a second end connected to an infusion hole 1008B disposed in the housing 1002 of the tissue expander 1000. In one embodiment, when pressure is provided inside the first injection chamber 1055A, the second check valve 1058B opens to allow the infusion fluid to flow through the infusion conduit 1036B through the second check valve 1058B and out of the infusion hole 1008B to bathe the outside of the housing 1002 with the infusion fluid.

[0169] In one embodiment, the second injection port 1004B of the tissue expander 1000 can be used to inflate and deflate the housing 1002 of the tissue expander 1000. In one embodiment, the second injection port 1004B advantageously includes a second injection chamber 1055B and a third valve 1058C that are open under pressure and vacuum. In one embodiment, when the inflation fluid is injected into the second injection chamber 1055B via the needle 1042, the fluid under pressure opens the third check valve 1058C, and the fluid enters the interior area of ​​the housing 1002 to inflate the tissue expander 1000. When a vacuum is drawn in the second injection chamber 1055B, the third check valve 1058C opens to allow the fluid inside the housing 1002 to be drawn out into the second injection chamber 1055B to be removed from the housing 1002, thereby defl ucting the tissue expander 1000.

[0170] Fig.21Various systems and devices are shown that can be used to create a vacuum to drain fluid that has accumulated around a tissue expander disclosed herein after the tissue expander has been implanted in a patient. The device can be coupled to a drainage catheter, injection chamber, and / or injection port disclosed herein for withdrawing any fluid that has accumulated around the exterior of the housing of the corresponding tissue expander. In one embodiment, the system for creating a vacuum preferably includes a compressible bulb 1115. In one embodiment, a vacuum can be created using a flexible, compressible reservoir 1125 that draws a substantially constant vacuum to allow for uniform and continuous removal of fluid from a surgical incision through a wound drainage catheter, such as the surgical fluid drain disclosed in U.S. Pat. No. 4,429,693 to Blake et al., the disclosure of which is hereby incorporated by reference herein. In one embodiment, a system having a metering container 1035 can be used to create a vacuum to allow for uniform and continuous removal of fluid from a surgical site.

[0171] In one embodiment, see Fig.22A , Fig. 22B , the drainage tube 140' preferably has an elongated cylindrical core 166' with four struts 168' that radially protrude from the core 166' along the longitudinal axis of the core. The radial struts 168' are preferably of equal size and are spaced at equal angles relative to each other. Each of the outer ends of the radial struts 168' has a corresponding overhang 170' that extends longitudinally throughout the entire length of the radial strut 168'. In one embodiment, as Figure 6B As shown, the overhang 170' is a thin arc-shaped member extending an equal distance on either side of its corresponding radial strut 168'. Therefore, the overhang 170' and the corresponding radial strut 168' are combined to form four T-shaped members. The size of the overhang 170' is set to form a segmented circle at the periphery of the drainage tube 140', with small gaps between adjacent overhangs 170'. Each of these gaps forms a longitudinal groove 172', which is parallel to the longitudinal axis of the core 166' and extends throughout the entire length of the drainage tube 140'. The core portion 166', the radial strut 168' and the overhang 170' are combined to form a plurality of channels or lumens 174' extending along the length of the drainage tube 140'. The longitudinal groove 172' allows fluid communication between the corresponding lumen 174' and the wound. In one embodiment, the width of the longitudinal groove 172' is approximately 0.05-0.2 times the outer diameter of the drain tube 140', which ensures adequate tissue contact in the drainage area while inhibiting tissue growth or debris such as clots from entering the lumen 174'.

[0172] After breast reconstruction surgery, patients will be placed with surgical drains to prevent blood and lymph from accumulating under the skin, allowing for faster recovery. Some patients are sent home with drains implanted in the body and connected to external reservoirs. Emptying these reservoirs can be traumatic because the patient must measure and empty the reservoir every morning. Patients cannot wait to have the drains removed. It would be very beneficial for patients to have a device for removing seroma fluid without having to attach drains 24 hours a day.

[0173] See also Fig.23A and Fig. 23B In one embodiment, an injection port assembly 1200 for an implant (such as a tissue expander or a breast implant) preferably includes an injection dome 1202 fixed to the upper end of a needle guard 1204, the needle guard having a drainage port 1208 and one or more inflation ports 1206, the one or more inflation ports being in fluid communication with an inflation chamber located inside the needle guard 1204, and the drainage port being in fluid communication with a drainage chamber located inside the needle guard 1204. The injection port assembly 1200 may have the upper end of the present patent application. Figure 3 One or more of the components and / or features disclosed in the injection port assembly 104 shown and described.

[0174] See also Fig. 23B In one embodiment, the injection port assembly 1200 may include a magnet box 1210 secured to the underside of the needle guard 1204. In one embodiment, the magnet box 1210 advantageously contains a magnet (not shown) that medical personnel can use to locate the center 1212 of the injection dome 1202. After the injection port 1200 has been implanted in a patient (e.g., as part of a breast reconstruction procedure), the magnet disposed within the magnet box 1210 preferably enables medical personnel to locate the center 1212 of the injection dome 1202 so that a needle inserted into the injection dome 1202 will be within the perimeter of the needle guard 1204 and will not extend outside the needle guard, where the needle could damage the housing of the implant or injure the patient.

[0175] See also Figure 24A-Figure 24D In one embodiment, the needle guard 1204 preferably includes a needle guard edge 1214 having an upper end 1216 and a lower end 1218. In one embodiment, the upper end 1216 of the needle guard edge 1214 is advantageously open and adapted to receive the injection dome 1202 ( Fig.23A ), as will be described in more detail herein. In one embodiment, the needle guard 1204 advantageously has a needle guard base 1220 located at the lower end 1218 of the needle guard edge 1214 for closing the bottom of the needle guard 1204. In one embodiment, the needle guard edge 1214 can have a cylindrical shape.

[0176] See also Fig.24A , Fig.24C and Fig.24D In one embodiment, the needle guard base 1220 of the needle guard 1204 preferably includes a barrier film support 1222 protruding upward from the needle guard base 1220 of the needle guard 1204. The barrier film support 1222 preferably supports the underside of the barrier film to prevent the barrier film from bulging and / or collapsing when the distal end of the needle is pressed against the barrier film and / or pressed into the barrier film. In one embodiment, the barrier film support 1222 preferably has a circular shape. The barrier film support may include two or more elements (e.g., opposing semicircles) spaced apart from each other. In one embodiment, the barrier film support may include a plurality of spaced apart posts protruding from the top surface of the needle guard base 1220, the posts having an upper end suitable for engaging the barrier film, such as the bottom surface of the barrier film, for supporting the barrier film inside the injection dome 1204.

[0177] See also Fig.24A , Fig. 24B and Fig.24D In one embodiment, the needle guard edge 1214 of the needle guard 1204 preferably includes a series of elongated slots 1224A-1224D extending through the needle guard edge 1214 adjacent to the upper end 1216 of the needle guard edge 1214. In one embodiment, the elongated slots 1224A-1224D are advantageously arranged along the longitudinal axis A1 ( Fig.24D ) extends and is aligned with a plane P1 ( Fig.24D )parallel.

[0178] See also Fig.24A , Fig. 24B and Fig.24D In one embodiment, the needle guard 1204 advantageously includes inflation ports 1206A, 1206B formed in the needle guard edge 1214 and in fluid communication with the inflation chamber of the injection port assembly 1200 ( Fig. 23B ). The needle guard 1204 preferably includes a drainage port 1208 that advantageously passes through the needle guard edge 1214 and is in fluid communication with the drainage chamber of the injection port assembly. Fig.24D In one embodiment, a barrier membrane 1234 is located inside the needle guard 1204 to separate the inflation chamber 1236 from the drainage chamber 1238. In one embodiment, the barrier membrane support 1222 advantageously supports the underside of the barrier membrane 1234 to prevent the barrier membrane from bulging when the distal end of the needle assembly is pressed against the barrier membrane 1234.

[0179] See also Figure 25A-Figure 25CIn one embodiment, the injection dome 1202 preferably has a cover 1226 defining a first diameter D1 and a base 1228 extending from the underside of the cover 1226, the base having a second diameter D2 that is smaller than the first diameter D1. In one embodiment, the cover 1226 has a circular shape, and the base 1228 has a circular or cylindrical shape.

[0180] In one embodiment, the base 1228 of the injection dome 1202 has a bottom surface 1230 having an annular groove 1232 formed therein that is adapted to receive the upper end 1216 ( Fig. 24B ) to secure the injection dome to the needle guard. Fig.25B and Fig.25C , an annular groove 1232 formed in the bottom surface 1230 of the base 1228 extends from the bottom surface 1230 toward the cover 1226 of the injection dome 1202. Fig.25C In one embodiment, the annular groove 1232 preferably defines a third diameter D3 that is smaller than the second diameter D2 of the base 1228 of the injection dome 1202.

[0181] See also Fig.26 In one embodiment, the injection dome 1202 can be assembled with the needle guard 1204 by juxtaposing the bottom surface 1230 of the base 1228 of the injection dome 1202 with the upper end 1216 of the needle guard edge 1214 of the needle guard 1204. In one embodiment, the needle guard 1204 has a first height H1, and the injection dome 1202 has a second height H2 that is less than the first height H1 of the needle guard.

[0182] In one embodiment, a silicone material (such as an uncured silicone material or one or more uncured silicone sheets) or an adhesive material (such as RTV) can be used to secure the injection dome to the needle guard. In one embodiment, the uncured silicone sheet can be positioned at the upper end of the needle guard, and after the upper end of the needle guard and the uncured silicone sheet are inserted into the annular groove 1232 of the injection dome 1202, heat can be used to cure the uncured silicone sheet to adhere the injection dome to the needle guard.

[0183] In one embodiment, the injection port assembly 1200 advantageously includes a barrier film 1234 that divides the interior of the needle guard into an inflation chamber 1236 that communicates with inflation ports 1206A, 1206B formed in the needle guard edge 1214 of the needle guard 1204 and a drainage chamber 1238 that is in fluid communication with the drainage port 1208 formed in the needle guard edge 1214 of the needle guard 1204. In one embodiment, the barrier film 1234 preferably extends across the entire width and / or diameter of the needle guard edge 1214 of the needle guard 1204 to separate the inflation chamber 1236 from the drainage chamber 1238. The barrier film support 1222 advantageously protrudes upward from the needle guard base 1220 of the needle guard 1204 to support the underside of the barrier film 1234.

[0184] See also Fig.26 and Fig. 27 In one embodiment, to assemble the injection dome with the needle guard, the annular groove 1232 formed in the bottom surface 1230 of the base 1228 of the injection dome 1202 is advantageously juxtaposed and aligned with the cylindrical needle guard edge 1214 of the needle guard 1204. In one embodiment, the shape and size of the annular groove 1232 of the injection dome and the shape and size of the cylindrical needle guard edge 1214 of the needle guard match each other.

[0185] In one embodiment, to secure the injection dome to the needle guard (e.g., to form an airtight seal), a connecting member such as a silicone sheet 1240 may be positioned around the needle guard edge 1214 of the needle guard 1204. In one embodiment, the silicone sheet 1240 is aligned with and covers the elongated slots 1224A-1224D located at the upper end 1216 of the needle guard edge 1214 of the needle guard 1204. Fig.24A and Fig. 24B In one embodiment, the injection dome 1202 is pressed onto the upper end 1216 of the needle guard edge 1214 of the needle guard 1204 so that the upper end 1216 of the outer wall of the needle guard and the silicone sheet 1240 ( Fig.26 ) is disposed within an annular groove 1232 formed in the underside of the injection dome 1202. The silicone sheet 1240 preferably forms a secure, waterproof attachment (e.g., heat seal, seal formed using a silicone adhesive) between the injection dome 1202 and the needle guard edge 1214 of the needle guard 1204.

[0186] See also Fig. 27In one embodiment, after the injection dome 1202 has been secured to the upper end 1216 of the needle guard edge 1214 of the needle guard 1204, the drainage chamber 1238 of the injection port assembly 1200 in fluid communication with the drainage port 1208 is preferably located between the top surface of the barrier film 1234 and the bottom surface 1230 of the base 1228 of the injection dome 1202. The inflation chamber 1236 in fluid communication with the inflation ports 1206A, 1206B extending through the needle guard edge 1214 of the needle guard 1204 is preferably located between the bottom surface of the barrier film 1234 and the top surface of the needle guard base 1220 of the needle guard 1204. The barrier film support 1222 protruding from the top surface of the needle guard base 1220 of the needle guard 1204 preferably supports the underside of the barrier film 1234.

[0187] See also Fig.28 In one embodiment, the first anvil 1242A and the second anvil 1242B can be used to secure the injection dome 1202 to the needle guard 1204 ( Fig. 27 In one embodiment, the first anvil 1242A includes a first concave surface 1244A that substantially matches the injection dome 1202 ( Fig.25B ) of the outer periphery of the base 1228 and the outer surface of the cylindrical outer wall of the needle guard. The second anvil 1242B advantageously includes a second concave surface 1244B, which also matches the injection dome 1202 ( Fig.25B ) of the base 1228 and the shape of the outer surface of the cylindrical outer wall of the needle guard. The first anvil and the second anvil are preferably opposite to each other on opposite sides of the base of the injection dome.

[0188] See also Fig.29 In one embodiment, after the base 1228 of the injection dome 1202 has been pressed onto the upper end of the needle guard edge 1214 of the needle guard 1204 to contact the silicone sheet, the first concave surface 1244A and the second concave surface 1244B of the first anvil 1242A and the second anvil 1242B ( Fig.28 ) can be pressed against the outer surface of the base 1228 to place the silicone sheet 1240 ( Fig.26) are pressed into the elongated slots 1224A-1224D located at the upper end 1216 of the needle guard edge 1214 of the needle guard 1204. In one embodiment, the first anvil 1242A and the second anvil 1242B are pressed inwardly toward each other in opposite directions DIR3, DIR4 to compress the silicone sheet 1240 onto the outer surface of the base 1228 of the injection dome 1202, thereby bonding the injection dome to the needle guard and preferably forming a seal therebetween. In one embodiment, the bonding of the injection dome to the needle guard may include using one or more uncured silicone sheets or silicone adhesives to secure the injection dome to the needle guard. In one embodiment, heat may be used to cure the one or more silicone sheets of the silicone adhesive. In one embodiment, the silicone material is located in the elongated slot formed at the upper end of the needle guard to provide an anchor point for adhering the injection port to the needle guard. In one embodiment, after the first anvil 1242A and the second anvil 1242B have been used to secure the injection dome 1202 to the upper end of the needle guard 1204, the first anvil and the second anvil can be removed, thereby the injection port assembly 1200 has the characteristics of the present patent application. Fig. 23B , Fig. 27 and Fig.29 Configuration shown.

[0189] In one embodiment, the injection port assembly has a configuration whereby a single needle with a removable insert can be used both to inflate the implant shell and to drain fluid that has collected around the exterior of the implant shell. Fig.30 In one embodiment, the injection port assembly 1300 preferably includes an injection dome 1302 and a needle guard 1304 having a needle guard edge 1314 that is pressed into an annular groove 1332 provided at the lower side of the base of the injection dome 1302. The needle guard edge 1314 of the needle guard 1304 advantageously includes a first inflation port 1306A and a second inflation port 1306B and a drainage port 1308 located above the inflation port. The injection port assembly 1300 advantageously includes a barrier membrane 1334 that divides the interior area of ​​the needle guard 1304 into an inflation chamber 1336 located between the underside of the barrier membrane 1334 and the top surface of the needle guard base 1320 of the needle guard 1304, and a drainage chamber 1338 located between the top surface of the barrier membrane 1334 and the bottom surface 1330 of the base 1328 of the injection dome 1302. The inflation chamber 1336 is preferably in fluid communication with the inflation ports 1306A, 1306B formed in the needle guard edge 1314 of the needle guard 1304, and the drainage chamber 1338 is preferably in fluid communication with the drainage port 1308 formed in the outer wall of the needle guard.

[0190] In one embodiment, the needle assembly 1350 preferably includes a needle 1352 having an elongated shaft 1354 with a proximal end 1356 and a distal end 1358. In one embodiment, the needle assembly 1350 preferably includes an insert 1360 disposed within the elongated shaft 1354 of the needle 1352. The insert 1360 is preferably coupled to an actuator 1362 that is engageable to move the insert along the longitudinal axis of the elongated 1354 of the needle 1352 between an extended position for aligning the distal end of the insert 1360 with the inflation lumen 1366 of the needle 1352 and a retracted position for aligning the distal end of the insert 1360 with the drainage lumen 1368 of the needle 1352.

[0191] See also Figure 31A-Figure 31C In one embodiment, needle 1352 ( Fig.30 ) preferably includes a slender shaft 1354 of the needle, the slender shaft having a proximal end 1356 and a distal end 1358 including a sharp tip 1364, which facilitates passing the distal end 1358 of the slender shaft 1354 of the needle through an object (such as an injection dome disclosed herein). In one embodiment, the needle 1352 preferably includes an inflation lumen 1366 and a drainage lumen 1368, the inflation lumen being located at the distal end 1358 of the slender shaft 1354, the drainage lumen extending through the outer wall of the slender shaft and being located proximal to the inflation lumen 1366. As will be described in more detail herein, in one embodiment, when the distal end 1358 of the slender shaft 1354 of the needle 1352 is inserted into the injection dome of the injection dome assembly, the inflation lumen 1366 is in fluid communication with the inflation chamber 1336 of the injection port assembly 1300 ( Fig.30 ), and the drainage lumen 1368 is fluidically connected to the drainage chamber 1338 of the injection port assembly 1300 ( Fig.30 ).

[0192] See also Fig.31C In one embodiment, the needle 1352 preferably includes an elongated conduit 1370 extending along the length of the elongated shaft 1354 of the needle. The elongated conduit 1370 is preferably in fluid communication with both the inflation lumen 1366 and the drainage lumen 1368.

[0193] See also Fig.32A and Fig.32B In one embodiment, needle assembly 1350 ( Fig.30 ) preferably includes an insert 1360 disposed within the elongated shaft of the needle 1354 ( Fig.31A). In one embodiment, the plug 1360 preferably includes an elongated shaft 1372 having an elongated conduit 1380 extending along the length of the plug from a proximal end 1374 of the plug to a distal end 1376. The distal end 1376 of the elongated shaft 1372 of the plug advantageously has a side port 1378 in fluid communication with the elongated conduit 1380 of the plug 1360. The distal end 1376 of the elongated shaft 1372 of the plug 1360 is closed by a distal end wall 1381. The actuator 1362 ( Fig.32A ) is fixed to the outer surface of the elongated shaft 1372 of the plug 1360 to allow medical personnel to adjust the position of the needle 1352 ( Fig.31A ) moves the insert between an extended position and a retracted position, in which the side port 1378 of the insert aligns with the inflation lumen 1366 of the needle ( Fig.31B ) fluid is connected, and in the retracted position, the side port 1378 of the plug is connected to the drainage lumen 1368 of the needle ( Fig.31B ) fluid connected.

[0194] See also Fig.32B In one embodiment, a side port 1378 is formed in the outer wall of the elongated shaft 1372 of the insert 1360. The side port 1378 is preferably located adjacent to the distal end 1376 of the elongated shaft 1372. In one embodiment, the side port 1378 is preferably in fluid communication with an elongated conduit 1380 extending along the length of the elongated shaft 1372. In one embodiment, the elongated conduit 1380 preferably extends between the proximal end 1374 and the distal end 1378 of the elongated shaft 1372 of the insert 1360 ( Fig.32A ).

[0195] See also Fig.33 In one embodiment, the insert 1360 is preferably disposed within the elongated shaft 1354 of the needle 1352 to form Fig.30 Needle assembly 1350 is shown. Insert 1360 preferably includes a side port 1378 that is in fluid communication with an elongated conduit 1380 extending along the length of insert 1360. Elongated shaft 1354 of needle 1352 preferably includes an inflation lumen 1366 positioned adjacent to distal end 1358 of elongated shaft 1354 and a drainage lumen 1368 located proximal to inflation lumen 1366.

[0196] See also Fig.33 and Fig.34 In one embodiment, plugin 1360 can Fig.33 Extended position shown and Fig.34 between the retracted positions shown. Fig.33In the extended position shown, the side port 1378 of the insert 1360 is aligned with the inflation lumen 1366 located at the distal end 1358 of the elongated shaft 1354 of the needle 1352. Fig.33 In the extended position shown, the outer wall of the slender shaft 1372 of the plug 1360 covers the drainage lumen 1368 of the needle 1352, so that fluid cannot pass through the drainage lumen 1368 of the needle 1352.

[0197] In one embodiment, plugin 1360 may be moved to Fig.34 The retracted position shown aligns the side port 1378 of the insert with the drainage lumen 1368 of the elongated shaft 1354 of the needle 1352. In the retracted position, the closed distal end wall 1381 of the insert blocks the inflation lumen 1366 of the needle 1352 so that fluid cannot enter or leave the needle 1352 through the inflation lumen 1366 of the needle.

[0198] In one embodiment, actuator 1362 ( Fig.30 ) can be used to enable plugin 1360 in Fig.33 Extended position shown and Fig.34 Repeat the movement back and forth between the retracted positions shown. Fig.33 In the extended position, the side port 1378 of the plug 1360 is aligned with the inflation lumen 1366 of the needle 1352 so that fluid can exit the inflation lumen (e.g., be introduced into the inflation chamber 1336 ( Fig.30 ). When the plugin 1360 is offset and / or moved to Fig.34 When in the retracted position shown, the side port 1378 of the insert 1360 is preferably aligned with the drainage lumen 1368 of the needle 1352 so that the elongated conduit of the insert is aligned with the injection port assembly 1300 ( Fig.30 ) of the drainage chamber 1338( Fig.30 ) fluid connected.

[0199] See also Fig.35A and Fig.35B In one embodiment, the distal end 1358 of the elongated shaft 1354 of the needle 1352 can be inserted into the injection dome 1302 of the injection port assembly 1300 until the distal end 1358 of the needle 1352 abuts the needle guard base 1320 of the needle guard 1304. In one embodiment, the plug 1360 can be offset into the extended position so that the side port 1378 of the plug 1360 is aligned with the inflation lumen 1366 of the needle 1352. When the plug 1360 is in Fig.35A and Fig.35B In the extended position shown, the distal end 1358 of the needle 1352 is in fluid communication with the inflation chamber 1336 of the injection port assembly 1300, whereby the needle can be used to introduce fluid into the inflation chamber 1336 to inflate the housing and / or provide an infusion fluid around the exterior of the housing.

[0200] See also Fig.36 In one embodiment, the actuator 1362 of the needle assembly 1350 is connected to the elongated shaft of the plug 1360 to enable the plug to move from Fig.33 The extended position shown moves to Fig.34 Shown in retracted position.

[0201] See also Fig.37A and Fig.37B In one embodiment, when the insert 1360 is in the retracted position, the side port 1378 of the insert 1360 is aligned with the drainage lumen 1368 of the elongated shaft 1354 of the needle 1352. The distal end wall 1381 located at the distal end of the elongated shaft 1372 of the insert 1360 closes the inflation lumen 1366 at the distal end 1358 of the needle 1352. In the retracted position, the side port 1378 of the insert 1360 is aligned with the drainage lumen 1368 of the needle 1352, so that the needle 1352 is in fluid communication with the drainage chamber 1338 of the injection port assembly 1300. Therefore, fluid drawn into the drainage port 1308 can be drawn into the drainage lumen 1368 to be removed from the proximal end of the needle 1352.

[0202] See also Fig.38 In one embodiment, the injection port assembly 1400 may include a barrier film support 1422 adapted to support a barrier film 1434 located inside the needle guard. In one embodiment, the barrier film 1434 preferably includes an inner barrier film 1484 having a central opening 1486 and an outer barrier film 1488 having an annular opening 1490 in the center.

[0203] In one embodiment, the barrier film support 1422 preferably includes an annular outer wall 1492, an annular inner wall 1494, the annular outer wall having an inner surface including an inner annular groove 1493, the annular inner wall having an outer surface including an outer annular groove 1495 and an inner surface including an inner annular groove 1496. In one embodiment, the barrier film support 1422 preferably includes a central column 1497 ( Fig.39 The barrier film support 1422 preferably has a bottom wall 1498 that closes the bottom of the barrier film support 1422. The outer annular wall 1492, the inner annular wall 1494 and the center column 1497 ( Fig.39 ) preferably protrudes away from the bottom wall 1498 of the barrier film support 1422.

[0204] See also Fig.39 In one embodiment, the inner barrier membrane 1484 is preferably pressed onto the central post 1497, wherein the central post passes through the central opening 1486 ( Fig.38The outer periphery of the inner barrier film 1484 is preferably disposed in an inner annular groove 1496 ( Fig.38 )Inside.

[0205] In one embodiment, the outer barrier film 1488 is preferably pressed into the space between the outer annular wall 1492 and the inner annular wall 1494. The outer periphery of the outer barrier film 1488 is preferably disposed within the inner annular groove 1493 of the outer annular wall 1492, and the inner periphery of the outer barrier film 1488 is preferably disposed within the outer annular groove 1495 formed in the inner annular wall 1494.

[0206] After the inner barrier film 1484 and the outer barrier film 1488 have been assembled with the barrier film support 1422, the barrier film 1434 preferably divides the barrier film support 1422 into an inflation chamber 1436 and a drainage chamber 1438, wherein the inflation chamber is arranged between the lower side of the barrier film 1434 and the top surface of the bottom wall 1498 of the barrier film support 1422, and the drainage chamber is located above the barrier film 1434.

[0207] See also Fig.40 , in one embodiment, Fig.39 The barrier film support 1422 and barrier film 1434 shown can be juxtaposed with the open upper end of the needle guard 1404 having the needle guard edge 1414. In one embodiment, the bottom wall 1498 of the barrier film support 1422 is preferably juxtaposed with the opening at the upper end 1416 of the needle guard edge 1414 of the needle guard 1404. The barrier film support 1422 preferably passes through the opening at the upper end 1416 of the needle guard edge 1414 of the needle guard 1404 in the direction DIR5 until the bottom wall 1498 of the barrier film support 1402 abuts against the top surface of the needle guard base 1420 of the needle guard 1404.

[0208] See also Fig.41, after the barrier film support 1422 is fully inserted into the needle guard 1404, the bottom wall 1498 of the barrier film support 1422 preferably abuts the needle guard base 1420 of the needle guard 1404. The outer barrier film 1488 preferably extends between and is supported by annular grooves formed in the respective outer annular walls 1492 and inner annular walls 1494 of the barrier film support 1422. The inner barrier film 1484 is preferably supported by the inner annular wall 1494 and the central column 1497. The barrier film support 1422 preferably holds the inner barrier film 1484 and the outer barrier film 1488 at positions spaced apart from the bottom wall 1498 of the barrier film support. Thus, the barrier film 1434 defines an inflation chamber 1436 , which is preferably located between the underside of the barrier film 1434 and the top surface of the bottom wall 1498 of the barrier film support 1422 , and a drainage chamber 1438 , which is located above the barrier film 1434 .

[0209] See also Fig.42 In one embodiment, the implant housing 1500 preferably has a first expandable chamber 1502 and a second expandable chamber 1504 separated from the first expandable chamber 1502 by a membrane 1506 extending across the interior of the housing 1500. In one embodiment, the implant housing 1500 advantageously includes a multi-compartment injection dome 1508 having a first fluid compartment 1510 and a second fluid compartment 1512 separated from the first fluid compartment 1510.

[0210] In one embodiment, the first fluid compartment 1510 of the injection dome 1508 is in communication with the first expandable chamber 1502 of the implant housing 1500 via a first valve 1514. The second fluid compartment 1512 of the injection dome 1508 is advantageously in fluid communication with the second expandable chamber 1504 of the implant housing 1500 via a second valve 1516. In one embodiment, when the first fluid is introduced into the first fluid compartment 1510 of the injection dome 1508 using an injection needle 1518, the first expandable chamber 1502 of the housing 1500 can be expanded with the first fluid. When the needle 1518 is used to deliver the second fluid into the second fluid compartment 1512 of the injection dome 1508, the second expandable chamber 1504 of the implant housing 1500 can be expanded with the second fluid. The first fluid and the second fluid can have the same properties (e.g., both are saline solutions) or different properties (e.g., the first fluid is a saline solution and the second fluid is an antibiotic solution).

[0211] In one embodiment, injection needle 1518 may have a configuration similar to needle assembly 1350, wherein removable insert 1360 is as described above in the present patent application. Figure 30-37BThus, a needle can be inserted into the injection dome 1508, and without moving the position of the needle relative to the injection dome, the needle inserter can be moved between a retracted position and an extended position to access both the first fluid compartment 1510 and the second fluid compartment 1512 of the injection dome 1508. In one embodiment, when the inserter is in the retracted position, the needle can be used to introduce a fluid into the first fluid compartment 1510 of the injection dome 1508. In one embodiment, when the inserter is in the extended position, the needle can be used to introduce a fluid into the second fluid compartment 1512 of the injection dome 1508.

[0212] In one embodiment, the implant housing may include two or more expandable chambers (e.g., three expandable chambers). In one embodiment, each expandable chamber in the two or more expandable chambers is associated with the different fluid compartments of the injection dome. For example, in an embodiment in which the implant housing has four expandable chambers, the injection dome may have four fluid chambers, whereby each fluid chamber of the injection dome is connected to a different expandable chamber fluid in the expandable chamber of the implant housing. In one embodiment, the injection dome may have more fluid chambers than the number of expandable chambers present in the implant housing. For example, the injection dome may have four fluid chambers and a fifth fluid chamber, which are connected to the four corresponding expandable chamber fluids of the implant housing, and the fifth fluid chamber is connected to the drainage conduit fluid to drain the fluid collected around the implant housing exterior.

[0213] Although the foregoing relates to embodiments of the present invention, other and further embodiments of the present invention may be devised without departing from the basic scope of the present invention, which is limited only by the scope of the following claims. For example, the present invention contemplates that any feature shown in any embodiment described herein or incorporated by reference herein may be combined with any feature shown in any other embodiment described herein or incorporated by reference herein and still fall within the scope of the present invention.

Claims

1. A tissue expander with an integrated drainage tube, the tissue expander comprising: a housing having an injection port opening and one or more drainage holes formed in the housing and spaced apart from the injection port opening; an injection port assembly disposed in the injection port opening, wherein the injection port assembly forms a fluid-tight seal with the housing; The injection port assembly includes a needle guard having a needle guard base with a top surface; a barrier film disposed within the needle guard, the barrier film covering the top surface of the needle guard base, wherein the barrier film defines an inflation chamber, the inflation chamber being located between the top surface of the needle guard base and a bottom surface of the barrier film, and wherein the barrier film defines a drainage chamber within the needle guard, the drainage chamber covering the top surface of the barrier film; one or more inflation ports in fluid communication with the inflation chamber for inflating and deflating the housing with a first fluid; a drainage conduit in fluid communication with and extending between the drainage chamber and the one or more drainage holes formed in the housing to drain a second fluid from outside the housing; The drainage conduit includes a second end portion coupled to the drainage tube, the second end portion in turn being in fluid communication with the one or more drainage holes formed in the housing; a drainage manifold aligned with and covering the one or more drainage holes formed in the housing, The drainage manifold separates the first fluid used to inflate and deflate the housing from the second fluid drained from the outside of the housing.

2. The tissue expander according to claim 1, further comprising: a first needle having an inflation lumen at a distal tip, wherein the first needle is adapted to be inserted into the injection port assembly such that the inflation lumen of the first needle is aligned with the inflation chamber to selectively inflate and deflate the housing with the first fluid; A second needle having a closed distal end and a drainage lumen spaced proximally from the closed distal end, wherein the second needle is adapted to be inserted into the injection port assembly such that the drainage lumen of the second needle is aligned with the drainage chamber to drain the second fluid from outside the housing.

3. The tissue expander according to claim 1, further comprising a needle assembly adapted to be inserted into the injection port assembly, wherein the needle assembly has a first configuration and a second configuration, wherein in the first configuration, the inflation lumen of the needle assembly is in fluid communication with the inflation chamber to selectively inflate and deflate the housing using the first fluid, and in the second configuration, the drainage lumen of the needle assembly is in fluid communication with the drainage chamber to drain the second fluid from outside the housing.

4. The tissue expander of claim 3, wherein the needle assembly comprises: a needle having an elongated shaft having a proximal end and a distal end, the needle comprising the inflation lumen and the drainage lumen, the inflation lumen being located at the distal end of the elongated shaft aligned with the inflation chamber, the drainage lumen being located proximal to the inflation lumen aligned with the drainage chamber, wherein the barrier membrane separates the inflation lumen from the drainage lumen; an inserter disposed within the elongated shaft of the needle and movable between an extended position in which the inflation lumen is open and the drainage lumen is closed, and a retracted position in which the inflation lumen is closed and the drainage lumen is open.

5. The tissue expander of claim 4, wherein the inserter of the needle assembly comprises an elongated shaft having an open proximal end, a distal end closed by a distal end wall, and an elongated conduit extending from the proximal end to the distal end of the inserter, the inserter comprising a side port formed in an outer wall of the elongated shaft of the inserter, the side port communicating with the elongated conduit of the inserter, wherein the side port of the inserter is aligned with the inflation lumen of the needle when the inserter is in the extended position, and the side port of the inserter is aligned with the drainage lumen of the needle when the inserter is in the retracted position.

6. The tissue expander according to claim 1, further comprising: the needle guard, the needle guard comprising a needle guard edge extending upwardly from the needle guard base; A barrier film support protrudes from the top surface of the needle guard base toward the bottom surface of the barrier film for supporting a lower side of the barrier film.

7. A tissue expander according to claim 6, wherein the injection port assembly also includes an injection dome fixed to the upper end of the edge of the needle guard, wherein the injection dome includes a base having a bottom surface, an annular groove formed in the bottom surface, and wherein the upper end of the edge of the needle guard is disposed in the annular groove of the injection dome for fixing the injection dome to the needle guard.

8. The tissue expander of claim 7, wherein the needle guard rim has a first height, and wherein the injection dome has a second height that is less than the first height of the needle guard rim.

9. The tissue expander of claim 7, wherein the needle guard edge has one or more component openings formed therein, the one or more component openings being positioned adjacent the upper end of the needle guard edge, and wherein the one or more component openings are disposed within the annular groove of the injection dome.

10. The tissue expander of claim 9, further comprising a drainage port extending through the needle guard edge for interconnecting the drainage chamber and the drainage conduit, and wherein the drainage port is located between the bottom surface of the base of the injection dome and the needle guard base.

11. The tissue expander of claim 10, further comprising a silicone material covering the upper end of the needle guard edge and contacting the one or more component openings formed in the needle guard edge, wherein the silicone material secures the injection dome to the upper end of the needle guard edge.

12. The tissue expander of claim 10, wherein the drainage chamber is located between the bottom surface of the injection dome and the top surface of the barrier membrane.

13. The tissue expander of claim 12, wherein the one or more inflation ports extend through a lateral opening disposed in the needle guard edge, and wherein the one or more inflation ports are located between the drainage port and a top surface of the needle guard base.

14. The tissue expander of claim 1, wherein the drainage manifold includes a drainage manifold port, and wherein the second end of the drainage conduit is secured to the drainage manifold port for connecting the drainage conduit to the drainage manifold.

15. The tissue expander of claim 14, wherein the drainage conduit includes a one-way check valve configured to enable fluid passing through the drainage conduit to move in only one direction toward the drainage chamber of the injection port assembly.

16. The tissue expander of claim 15, wherein the drainage manifold has an inner face and an outer face, wherein the drainage manifold ports protrude from the inner face of the drainage manifold, and wherein the outer face of the drainage manifold is secured to the inner surface of the housing to form a watertight seal between the drainage manifold and the inner surface of the housing.

17. The tissue expander of claim 16, wherein the inner surface of the drainage manifold surrounds a slot, wherein the drainage tubes include one or more drainage tubes disposed in the slot and aligned with the one or more drainage holes formed in the housing, and wherein the drainage manifold port is in fluid communication with the slot and the one or more drainage tubes disposed within the slot.

18. The tissue expander according to claim 1, further comprising: the drainage manifold, the drainage manifold having an inner face and an outer face, the outer face of the drainage manifold forming a watertight seal with the inner surface of the housing and the outer face of the drainage manifold surrounding the one or more drainage holes formed in the housing; The drainage tube comprises a sealing drainage cover fixed to the inner surface of the drainage manifold, wherein the second end of the drainage conduit is coupled to the drainage manifold.

19. The tissue expander according to claim 1, further comprising: an infusion chamber covering the top surface of the barrier membrane and separated from the drainage chamber; An infusion conduit is in fluid communication with and extends between the infusion chamber and at least one of the one or more drainage holes formed in the housing for delivering an infusion fluid to an exterior of the housing.

20. A tissue expander with an integrated drainage tube, the tissue expander comprising: a housing having an injection port opening and one or more drainage holes formed in the housing; an injection port assembly disposed in the injection port opening for forming a fluid-tight seal with the housing; The injection port assembly includes a needle guard having a needle guard base with a top surface, and a needle guard edge extending upward from the needle guard base and surrounding an outer periphery of the needle guard base; a barrier film disposed within the needle guard, the barrier film covering the top surface of the needle guard base; The barrier membrane defines an inflation chamber located between the top surface of the needle guard base and the bottom surface of the barrier membrane for inflating and deflating the housing with a first fluid; The needle guard edge has one or more lateral openings defining one or more housing inflation ports in fluid communication with the inflation chamber; The barrier membrane defines a drainage chamber within the needle guard, the drainage chamber covering a top surface of the barrier membrane for draining a second fluid from an exterior of the housing through the one or more drainage holes; a needle assembly configured to be inserted into the injection port assembly, wherein the needle assembly has a first configuration and a second configuration, wherein in the first configuration, the inflation lumen of the needle assembly is in fluid communication with the inflation chamber to selectively inflate and deflate the housing using the first fluid, and in the second configuration, the drainage lumen of the needle assembly is in fluid communication with the drainage chamber to drain the second fluid from outside the housing, a drainage conduit in fluid communication with and extending between the drainage chamber and the one or more drainage holes formed in the housing to drain a second fluid from outside the housing; a drainage manifold aligned with and covering the one or more drainage holes formed in the housing, The drainage manifold separates the first fluid used to inflate and deflate the housing from the second fluid drained from the outside of the housing.

21. The tissue expander of claim 20, further comprising a barrier membrane support protruding from the top surface of the needle guard base toward the bottom surface of the barrier membrane.

22. The tissue expander according to claim 20, further comprising: The injection port assembly comprises an injection dome fixed to the upper end of the edge of the needle guard; the injection dome comprises a base having a bottom surface, an annular groove being formed in the bottom surface, wherein the upper end of the edge of the needle guard is arranged in the annular groove of the injection dome for fixing the injection dome to the needle guard.

23. The tissue expander of claim 22, further comprising: the needle guard edge having one or more assembly openings formed therein, the one or more assembly openings being positioned adjacent the upper end of the needle guard edge, wherein the one or more assembly openings are disposed within the annular groove of the injection dome; and A silicone material covers the upper end of the needle guard rim and contacts the one or more component openings formed in the needle guard rim, wherein the silicone material secures the injection dome to the upper end of the needle guard rim.